Impact of COVID-19 in immunosuppressive drug-naive autoimmune disorders: Autoimmune gastritis, celiac disease, type 1 diabetes, and autoimmune thyroid disease

Santacroce, G; Lenti, MV; Aronico, N; Miceli, E; Lovati, E; Lucotti, PC; Coppola, L; Gentile, A; Latorre, MA; Di Terlizzi, F; Soriano, S; Frigerio, C; Pellegrino, I; Pasini, A; Ubezio, C; Mambella, J; Canta, R; Fusco, A; Rigano, G; Di Sabatino, A

Di Sabatino, A (通讯作者),Univ Pavia, San Matteo Hosp Fdn, Dept Internal Med, Pavia, Italy.

PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022; 33 (): 105

Abstract

Few conflicting data are currently available on the risk of SARS-CoV-2 infection in patients with autoimmune disorders. The studies performed so far a......

Full Text Link